Jonathan Trinh

Jonathan Trinh is a Senior Associate in the Life Sciences and Healthcare Regulatory practice group at Arnold & Porter. He advises pharmaceutical, biotechnology, and medical device companies — from emerging innovators to established market leaders — on navigating FDA regulatory requirements across the full product lifecycle.

Jonathan partners with clients to design and execute FDA regulatory strategies aligned with business objectives, including efficient commercial launches and value-maximizing exit opportunities. He counsels clients on pre-clinical development, approval pathways, post-market compliance, and evolving FDA requirements. He also advises on advertising and promotional matters, including direct-to-consumer campaigns, social media engagement, and influencer partnerships.

In addition to his regulatory practice, Jonathan brings experience in high stakes transactional and enforcement-related matters. He conducts FDA regulatory diligence in connection with mergers, acquisitions, and licensing transactions, providing investors and companies with clear assessments of regulatory risk. He also represents clients in internal and congressional investigations involving alleged violations of FDA and healthcare laws.

Prior to joining Arnold & Porter, Jonathan trained with leading FDA and healthcare regulatory practices at two global law firms and served as a judicial intern to the Honorable Rudolph Contreras of the U.S. District Court for the District of Columbia.